Submitted by Anonymous (not verified) on 1 August 2023 - 9:03
Human medicines European public assessment report (EPAR): Xydalba, dalbavancin, Soft Tissue Infections;Skin Diseases, Bacterial, Date of authorisation: 19/02/2015, Revision: 15, Status: Authorised
Source: